by Willian Upton, The National Pulse:
A study published by Turkish researchers in Istanbul raises new concerns over Pfizer-BioNTech‘s BNT162b2 mRNA vaccine for COVID-19 and its impact on children’s neurological development during pregnancy. The research, published on January 10th in the peer-reviewed Neurochemical Research journal, found the vaccine had a “profound impact on key neurodevelopmental pathways” in male and female laboratory rat offspring.
The scientists tested the BNT162b2 vaccine on 40 pregnant rat specimens during gestation — using “molecular techniques” to track changes to the genetic protein WNT, which is responsible for neurological development impacting social behavior and memory. When the male and female rat offspring were examined after birth, the Turkish scientists found evidence of “autism-like behaviors” and effects on “motor performance.”
TRUTH LIVES on at https://sgtreport.tv/
“Our findings reveal that the mRNA BNT162b2 vaccine significantly alters WNT gene expression and BDNF levels in both male and female rats, suggesting a profound impact on key neurodevelopmental pathways,” the scientist wrote, adding: “Notably, male rats exhibited pronounced autism-like behaviors, characterized by a marked reduction in social interaction and repetitive patterns of behavior.”
The laboratory study adds: “Furthermore, there was a substantial decrease in neuronal counts in critical brain regions, indicating potential neurodegeneration or altered neurodevelopment. Male rats also demonstrated impaired motor performance, evidenced by reduced coordination and agility.”
Despite the findings, the scientists who authored the study cautioned against drawing any conclusions on the vaccine’s efficacy beyond rat populations. “More extensive studies are needed to confirm these observations in humans,” they note.
The National Pulse previously reported that the U.S. Centers for Disease Control and Prevention (CDC) pulled a draft alert to state and local health officials warning of increased incidents of myocarditis in young people receiving the Pfizer-BioNTech or Moderna mRNA vaccines.